APASL 2021 - 30th Annual Conference of the Asian Pacific Association for The Study of the Liver (Virtual Meeting)
Feb 04 - Feb 06, 2021 | BangkokThailand
LARVOL is not affiliated with 30th Annual Conference of the Asian Pacific Association for The Study of the Liver (Virtual Meeting) and all trademarks, logos, and brand names are property of their respective owners
Condition
Product
MOA
Trial Name/ID
Showing 2 abstracts linked to Trials
[VIRTUAL] The Novel Regimen of a Single, Priming Dose of Tremelimumab (T) + Durvalumab (D) in Patients With Unresectable Hepatocellular Carcinoma (uHCC) by Viral Etiology
[VIRTUAL] IMbrave150: updated overall survival (OS) data from a global, randomized, open-label Phase III study of atezolizumab + bevacizumab vs sorafenib in unresectable hepatocellular carcinoma (HCC)